Supply of Medicine and Medical / Surgical equipments : Lipoomal form of Ampotericin B 50mg vial\nLiposomal form of Amphotericin B 50 mg vial\nA sterile, pyrogen free, lyophilized powder for\ndispersion for infusion.\nEach vial should contain as active ingredient 50 mg\n(50,000 units) of Amphotericin B intercalated in\nliposomes. After reconstitution in sterile water for\ninjection, the concentrated solution should contain\n4mg/ml of Amphotericine B.\nEach vial should be packed individually in a carton\nwith a product information leaflet including details\non administration and a device for filtration with the\nmean pore diameter of the filter not less than 1.0\nmicron.\nPrequalification\nThe manufacturer should have the following\ndocuments\n1) Certificate of registration in\na. the country of manufacturer\nb. Sri Lanka\nc. other countries where the product is registered\n2) Evidence of current use in the country of\nmanufacture\n3) Evidence of current use in reference countries\nnamely USA, UK and Ireland. Australia, Canada,\nGermany, Japan, Italy\n4) Evidence of WHO pre-qualification is preferable etc .

STATE PHARMACEUTICALS CORPORATION OF SRI LANKA Sri Lanka has Released a tender for Supply of Medicine and Medical / Surgical equipments : Lipoomal form of Ampotericin B 50mg vial\nLiposomal form of Amphotericin B 50 mg vial\nA sterile, pyrogen free, lyophilized powder for\ndispersion for infusion.\nEach vial should contain as active ingredient 50 mg\n(50,000 units) of Amphotericin B intercalated in\nliposomes. After reconstitution in sterile water for\ninjection, the concentrated solution should contain\n4mg/ml of Amphotericine B.\nEach vial should be packed individually in a carton\nwith a product information leaflet including details\non administration and a device for filtration with the\nmean pore diameter of the filter not less than 1.0\nmicron.\nPrequalification\nThe manufacturer should have the following\ndocuments\n1) Certificate of registration in\na. the country of manufacturer\nb. Sri Lanka\nc. other countries where the product is registered\n2) Evidence of current use in the country of\nmanufacture\n3) Evidence of current use in reference countries\nnamely USA, UK and Ireland. Australia, Canada,\nGermany, Japan, Italy\n4) Evidence of WHO pre-qualification is preferable etc . in Pharmaceuticals. The tender was released on Oct 16, 2024.

Country - Sri Lanka

Summary - Supply of Medicine and Medical / Surgical equipments : Lipoomal form of Ampotericin B 50mg vial\nLiposomal form of Amphotericin B 50 mg vial\nA sterile, pyrogen free, lyophilized powder for\ndispersion for infusion.\nEach vial should contain as active ingredient 50 mg\n(50,000 units) of Amphotericin B intercalated in\nliposomes. After reconstitution in sterile water for\ninjection, the concentrated solution should contain\n4mg/ml of Amphotericine B.\nEach vial should be packed individually in a carton\nwith a product information leaflet including details\non administration and a device for filtration with the\nmean pore diameter of the filter not less than 1.0\nmicron.\nPrequalification\nThe manufacturer should have the following\ndocuments\n1) Certificate of registration in\na. the country of manufacturer\nb. Sri Lanka\nc. other countries where the product is registered\n2) Evidence of current use in the country of\nmanufacture\n3) Evidence of current use in reference countries\nnamely USA, UK and Ireland. Australia, Canada,\nGermany, Japan, Italy\n4) Evidence of WHO pre-qualification is preferable etc .

Deadline - Nov 26, 2024

GT reference number - 95621307

Product classification - Pharmaceutical products